BIOMAT Database Logo BIOMAT Database Logo

The effect of clofibrate on the elimination of cholesterol as bile acids in patients with hyperlipoproteinaemia type II and IV. 1973

K Einarsson, and K Hellström, and M Kallner

UI MeSH Term Description Entries
D006949 Hyperlipidemias Conditions with excess LIPIDS in the blood. Hyperlipemia,Hyperlipidemia,Lipemia,Lipidemia,Hyperlipemias,Lipemias,Lipidemias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002250 Carbon Radioisotopes Unstable isotopes of carbon that decay or disintegrate emitting radiation. C atoms with atomic weights 10, 11, and 14-16 are radioactive carbon isotopes. Radioisotopes, Carbon
D002635 Chenodeoxycholic Acid A bile acid, usually conjugated with either glycine or taurine. It acts as a detergent to solubilize fats for intestinal absorption and is reabsorbed by the small intestine. It is used as cholagogue, a choleretic laxative, and to prevent or dissolve gallstones. Chenic Acid,Chenodeoxycholate,Chenodiol,Gallodesoxycholic Acid,Chenique Acid,Chenix,Chenofalk,Chenophalk,Henohol,Quenobilan,Quenocol,Sodium Chenodeoxycholate,Acid, Chenic,Acid, Chenique,Acid, Chenodeoxycholic,Acid, Gallodesoxycholic,Chenodeoxycholate, Sodium
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D002793 Cholic Acids The 3 alpha,7 alpha,12 alpha-trihydroxy-5 beta-cholanic acid family of bile acids in man, usually conjugated with glycine or taurine. They act as detergents to solubilize fats for intestinal absorption, are reabsorbed by the small intestine, and are used as cholagogues and choleretics. Cholalic Acids,Acids, Cholalic,Acids, Cholic
D002994 Clofibrate A fibric acid derivative used in the treatment of HYPERLIPOPROTEINEMIA TYPE III and severe HYPERTRIGLYCERIDEMIA. (From Martindale, The Extra Pharmacopoeia, 30th ed, p986) Athromidin,Atromid,Atromid S,Clofibric Acid, Ethyl Ester,Ethyl Chlorophenoxyisobutyrate,Miscleron,Miskleron,Chlorophenoxyisobutyrate, Ethyl
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes

Related Publications

K Einarsson, and K Hellström, and M Kallner
[Effect of clofibrate on lipoprotein-lipids in patients with type IV hyperlipoproteinaemia (author's transl)].
August 1977, Klinische Wochenschrift,
K Einarsson, and K Hellström, and M Kallner
Effect of clofibrate and calcium in type II A hyperlipoproteinaemia.
January 1977, Acta medica Scandinavica,
K Einarsson, and K Hellström, and M Kallner
Effect of combined administration of clofibrate and neomycin on serum cholesterol levels in familial type II hyperlipoproteinaemia.
January 1973, Current medical research and opinion,
K Einarsson, and K Hellström, and M Kallner
CI-924 effects on plasma lipids in patients with type II and type IV hyperlipoproteinaemia.
January 1989, European journal of clinical pharmacology,
K Einarsson, and K Hellström, and M Kallner
Effects of clofibrate and tiadenol on the elimination of lipids and bile acids in rat bile.
October 1981, Lipids,
K Einarsson, and K Hellström, and M Kallner
Effect of ursodeoxycholic acid on bile supersaturated with cholesterol in patients pretreated with clofibrate.
May 1981, Zeitschrift fur Gastroenterologie,
K Einarsson, and K Hellström, and M Kallner
Lipid-lowering effect of carnitine in patients with type-IV hyperlipoproteinaemia.
October 1978, Lancet (London, England),
K Einarsson, and K Hellström, and M Kallner
[Effect of hypophysectomy on elimination of cholesterol and bile acids in rats with permanent common bile duct fistula].
October 1972, Journal de physiologie,
K Einarsson, and K Hellström, and M Kallner
Fibrinogen catabolism in patients with type II and type IV hyperlipidemia. Effect of dietary and clofibrate treatment on laboratory findings.
January 1981, Arteriosclerosis (Dallas, Tex.),
K Einarsson, and K Hellström, and M Kallner
Coronary arteriographic findings in type-II and type-IV hyperlipoproteinaemia.
May 1976, Lancet (London, England),
Copied contents to your clipboard!